Trials / Completed
CompletedNCT00041977
Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Determine the Effects of Doxycycline Hyclate 20 Mg Tablets [Periostat(R)] Administered Twice Daily for the Treatment of Acne Rosacea
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (planned)
- Sponsor
- CollaGenex Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether Periostat(R), Doxycycline Hyclate 20 mg Tablets, taken twice daily is effective in reducing the red and white heads and overall redness associated with rosacea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | doxycycline hyclate 20 mg twice daily |
Timeline
- Start date
- 2002-06-01
- First posted
- 2002-07-23
- Last updated
- 2005-06-24
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00041977. Inclusion in this directory is not an endorsement.